Specific, sensitive, and rapid assay for human immunodeficiency virus type 1 pol mutations associated with resistance to zidovudine and didanosine.
The effectiveness of antiretroviral therapy may be limited by the development of human immunodeficiency virus type 1 (HIV-1) resistance. Monitoring for resistance will perhaps allow changes in therapy prior to deterioration in the patient's clinical or immunologic status. Our objective was to develo...
Guardat en:
| Publicat a: | J Clin Microbiol |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
1995
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC227945/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7714190/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jcm.33.2.342-347.1995 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|